In this video, Ankur Verma, Practice Director, and Gokul Janardhan, Senior Analyst, discuss the pharmacovigilance industry and how it’s become a significant market in terms of spend from life science enterprises, currently a US$19 billion market. Life science enterprises are now looking more at third party services to support and manage pharmacovigilance operations across the entire value chain.
Learn more in our viewpoint, The Evolving Pharmacovigilance (PV) Landscape.
Discover current challenges that life science enterprises are facing and what is driving this growth in the pharmacovigilance industry throughout this video.